AU2004263238A1 - Novel N-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament, and method for the production thereof - Google Patents

Novel N-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament, and method for the production thereof Download PDF

Info

Publication number
AU2004263238A1
AU2004263238A1 AU2004263238A AU2004263238A AU2004263238A1 AU 2004263238 A1 AU2004263238 A1 AU 2004263238A1 AU 2004263238 A AU2004263238 A AU 2004263238A AU 2004263238 A AU2004263238 A AU 2004263238A AU 2004263238 A1 AU2004263238 A1 AU 2004263238A1
Authority
AU
Australia
Prior art keywords
substituted
unsubstituted
alkyl
aryl
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004263238A
Other languages
English (en)
Inventor
Silke Baasner
Matthias Gerlach
Eckhard Gunther
Peter Schmidt
Tilmann Schuster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aeterna Zentaris GmbH
Original Assignee
Zentaris AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris AG filed Critical Zentaris AG
Publication of AU2004263238A1 publication Critical patent/AU2004263238A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2004263238A 2003-07-25 2004-07-09 Novel N-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament, and method for the production thereof Abandoned AU2004263238A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10334040.8 2003-07-25
DE10334040A DE10334040A1 (de) 2003-07-25 2003-07-25 Neue N-substituierte Indolyl-3-glyoxylsäureamide, deren Verwendung als Arzneimittel und Verfahren zu deren Herstellung
PCT/EP2004/007573 WO2005014542A2 (de) 2003-07-25 2004-07-09 Neue n-substituierte indolyl-3-glyoxylsäureamide, deren verwendung als arzneimittel gegen krebs und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
AU2004263238A1 true AU2004263238A1 (en) 2005-02-17

Family

ID=34129467

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004263238A Abandoned AU2004263238A1 (en) 2003-07-25 2004-07-09 Novel N-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament, and method for the production thereof

Country Status (18)

Country Link
EP (1) EP1651600A2 (uk)
JP (1) JP2007503376A (uk)
KR (1) KR20060037398A (uk)
CN (1) CN1839129A (uk)
AR (1) AR045928A1 (uk)
AU (1) AU2004263238A1 (uk)
BR (1) BRPI0412898A (uk)
CA (1) CA2533433A1 (uk)
DE (1) DE10334040A1 (uk)
IL (1) IL173335A0 (uk)
MX (1) MXPA06000995A (uk)
NO (1) NO20060697L (uk)
RS (1) RS20060049A (uk)
RU (1) RU2317293C9 (uk)
TW (1) TW200524863A (uk)
UA (1) UA83498C2 (uk)
WO (1) WO2005014542A2 (uk)
ZA (1) ZA200601300B (uk)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ596024A (en) 2006-08-07 2013-07-26 Ironwood Pharmaceuticals Inc Indole compounds
AR084433A1 (es) 2010-12-22 2013-05-15 Ironwood Pharmaceuticals Inc Inhibidores de la faah y composiciones farmaceuticas que los contienen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003022280A2 (en) * 2001-09-13 2003-03-20 Synta Pharmaceuticals Corp. 3-glyoxlylamideindoles for treating cancer

Also Published As

Publication number Publication date
AR045928A1 (es) 2005-11-16
WO2005014542A2 (de) 2005-02-17
UA83498C2 (uk) 2008-07-25
WO2005014542A3 (de) 2006-10-19
RS20060049A (en) 2008-08-07
RU2317293C9 (ru) 2008-05-10
CA2533433A1 (en) 2005-02-17
JP2007503376A (ja) 2007-02-22
IL173335A0 (en) 2006-06-11
CN1839129A (zh) 2006-09-27
EP1651600A2 (de) 2006-05-03
RU2006105708A (ru) 2006-06-27
RU2317293C2 (ru) 2008-02-20
KR20060037398A (ko) 2006-05-03
BRPI0412898A (pt) 2006-10-03
MXPA06000995A (es) 2006-04-11
NO20060697L (no) 2006-02-14
TW200524863A (en) 2005-08-01
ZA200601300B (en) 2007-03-28
DE10334040A1 (de) 2005-03-10

Similar Documents

Publication Publication Date Title
CN114269735B (zh) 二氢或四氢喹唑啉类化合物及其中间体、制备方法和应用
CN108383836B (zh) 作为mek抑制剂的杂环基化合物
CA2524525C (en) Novel pyridopyrazines and use thereof as kinase modulators
KR20050072824A (ko) 과다증식성 질환 및 혈관신생과 관련된 질병의 치료에유용한 인돌릴 피라지논 유도체
AU2004268948A1 (en) N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
WO2015077193A1 (en) Inhibitors of lysine methyl transferase
JP2007502822A (ja) ｃ−Ｋｉｔ阻害剤としてのＮ３−置換イミダゾピリジン誘導体
AU2004240746A1 (en) Novel pyridopyrazines and use thereof as kinase inhibitors
AU2003246571B2 (en) Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases
ES2450067T3 (es) Derivados de pirido[2,3-d]pirimidina, proceso para su preparación y su uso terapéutico
MX2011010329A (es) Derivados de quinoxalina y su uso para el tratamiento de trastornos de tumores benignos y malignos.
US7211588B2 (en) N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparation
CN110229171B (zh) 一种噁嗪并喹唑啉与噁嗪并喹啉类化合物及其制备方法和应用
US20050009809A1 (en) Acridine derivatives and their use as medicaments
EP4242207A1 (en) Kras inhibitors for treatment of cancers
AU2004263238A1 (en) Novel N-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament, and method for the production thereof
CN110229172B (zh) 一种酰基取代的噁嗪并喹唑啉类化合物、制备方法及其应用
CN111875583A (zh) 三氮唑衍生物及其制备方法和用途
WO2011078226A1 (ja) 三環系化合物
CN111868060B (zh) 二氢吡啶并酞嗪酮衍生物、其制备方法及应用
CN112441980A (zh) 用于fgfr抑制剂的吡唑类衍生物及其制备方法
CN114555597A (zh) 异柠檬酸脱氢酶（idh）抑制剂
CN114728910B (zh) 用于fgfr抑制剂的吡唑类衍生物及其制备方法
CN115894520A (zh) 一种大环k-ras g12c抑制剂及其制备方法和在药学上的应用
CN116529252A (zh) 用于持续释放治疗剂的前药及其用途

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application